Tubastatin A prevented AD from increasing ed expression levels of TSLP, Toll-like receptor 4 (TLR4), Myeloid differentiation 88 (MyD88), and NF-κB (Figure 2C), inducing the binding of HDAC6 to MyD88 (Figure 2D, left) and the binding of FcεRI to Lyn (Figure 2D, left). This evidence concerns the gene NFKB1 and Alzheimer disease.